CORE

🇺🇦   make metadata, not war

    2 research outputs found

    Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

    Author
    Publication venue
    'American Society of Hematology'
    Publication date
    Field of study
    No full text
    Crossref
    corecore